Applying the blood based biomarkers for Alzheimer’s disease – A clinical algorithm for primary care

Dr Stephanie Daly, A/Prof Michael Woodward, Clinical A/Prof Ramesh Manocha

writer

Dr Stephanie Daly, A/Prof Michael Woodward, Clinical A/Prof Ramesh Manocha

Claim CPD for this activity

Educational Activities (EA)

0.5 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0.5 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

1 hours

These are activities that use your work data to ensure quality results.

EA
0.5 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0.5 minutes

These are activities that require reflection on feedback about your work.

MO
1 minutes

These are activities that use your work data to ensure quality results.

Blood based biomarkers for Alzheimer’s disease represent new a paradigm in Alzheimer’s disease diagnosis in primary and secondary care.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

References

For further details on pTau181 visit this link.

For further details on pTau217 visit this link.

 

Alzheimer’s Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer’s disease within specialized care settings
https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.70535

 

Assessment process for Dementia Diagnosis – Cognitive Decline Partnership Centre
https://www.alz.org/getmedia/30685514-99c8-4f4a-9474-e2779b1d3b5c/e224a154-a199-4de6-92da-0b2f87727b70.pdf

 

Alzheimer’s Association® Clinical Practice Guideline: Integrating Blood-Based Biomarkers in Alzheimer’s Disease Specialized Care
https://cdpc.sydney.edu.au/wp-content/uploads/2019/06/sssessment-process-for-dementia-diagnosis.pdf

 

Palmqvist S, Tideman P, Mattsson-Carlgren N, et al. Blood biomarkers to detect Alzheimer disease in primary care and secondary care. JAMA. 2024;332(15):1245-1257.
Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Paige Lanyon-Roberts

Dr Paige Lanyon-Roberts

The New Oral Medications for Obesity – A Practical Guide for GPs

Dr Terri-Lynne South

Dr Terri-Lynne South

Oral GLP1s – What GPs Need to Know

Dr Katherine Spira

Dr Katherine Spira

Menstrual Migraine

Prof Danny Green

Prof Danny Green

GLP1s and Muscle Mass – What Does the Evidence Show?

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.